Seeking Alpha

Investorideas.com's  Instablog

Investorideas.com
Send Message
www.InvestorIdeas.com is a meeting place for investors and public companies in leading sectors. Find investing ideas, news and research for biotech stocks, tech and mobile stocks, mining stocks, oil and gas, water stocks, renewable energy, beverage stocks, defense stocks, nanotech and more on... More
My company:
Investor Ideas
My blog:
Investor Ideas Newswire
  • Biotech Stock Alert; (OTC: AEMD)) Trading Up 50.88% on News of $6.8 million Contract from Defense Advanced Research Projects Agency (DARPA) 0 comments
    Oct 3, 2011 12:36 PM | about stocks: AEMD
    Biotech Stock Alert; (OTC: AEMD)) Trading Up 50.88% on News of $6.8 million Contract from Defense Advanced Research Projects Agency (DARPA)
     
    Point Roberts, WA- October 3, 2011- Investorideas.com , an investor research portal specializing in sector research including biotech and pharma stocks, report Aethlon Medical (OTCBB: AEMD), a pioneer in developing therapeutic filtration devices is trading up at $0.0860, up 0.0290 (50.88%) on over 1.3 million shares in early morning trading.
     
    The Company reported news that it has been awarded a $6.8 million contract from the Defense Advanced Research Projects Agency (DARPA) to develop a therapeutic device to reduce the incidence of sepsis, a fatal bloodstream infection that is often the cause of death in combat-injured soldiers. The contract program will utilize the Aethlon ADAPT™ system as a core technology component underlying an extracorporeal blood purification device that selectively clears multiple sepsis-enabling particles from circulation to promote recovery and prevent sepsis. The resulting device, which is being advanced under DARPA's Dialysis Like Therapeutics (DLT) program, is expected to dramatically decrease the morbidity and mortality of sepsis, thereby saving thousands of lives and billions of dollars in the United States each year. Under the DLT program, Aethlon will also introduce a novel blood pump strategy to reduce or eliminate the systemic administration of anticoagulants normally required during extracorporeal device therapies. Worldwide, more than 18 million cases of sepsis are reported every year, with more than six million resulting in death.  
     
     
     
     
    Biotech Investor Snapshot for Aethlon Medical (OTCBB: AEMD)
    The Aethlon Medical mission is to create innovative medical devices that address unmet medical needs in cancer, infectious disease, and other life-threatening conditions. Aethlon's ADAPT™ platform provides the technology foundation for a new class of therapeutics that target the selective removal of disease enabling particles from the entire circulatory system. The Aethlon ADAPT™ product pipeline includes the Hemopurifier®, a first-in-class medical device with broad-spectrum capabilities against exosomes that contribute to the progression of cancer and infectious viral pathogens such as HIV and Hepatitis C. For more information, please visit www.aethlonmedical.com.
     
    Visit the AEMD showcase page on Investorideas.com
     
    Get biotech news and stock alerts 
     
    Research more biotech stocks at the Biotech stocks Directory: http://www.investorideas.com/BIS/Stock_List.asp
     
    About InvestorIdeas.com:
    InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
     
    Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
    Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
     
    Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.AETHLON MEDICAL INC(OTC BB: AEMD ) Showcase biotech,  biodefense and defense stock on Investorideas.com ( $one thousand five hundred per month, $five thousand per month in 144 stock)Effective March 15, 2011       
    BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
    800-665-0411 - Source – www.Investorideas.com
    Themes: biotech stocks Stocks: AEMD
Back To Investorideas.com's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers

StockTalks

  • Investing in Water Stocks for World Water Week being held in Stockholm, August 23 - 28, 2015. http://bit.ly/1hD9Wgd $AWR $WTR
    Aug 24, 2015
  • The Future of Money; Bitcoin & Ether Shake it up with CryptoCurrencies That Disrupt & Innovate $BITXF, $GBTC http://bit.ly/1VATr3Q
    Jul 23, 2015
  • Colombia's Free Trade Zones are Booming:Tax rates are not the only incentives-We met with Unisys CEO ($UIS) http://bit.ly/1VqUzXw
    Jul 21, 2015
More »
Posts by Themes
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.